NEWS
GREENSLEEVES REBRANDS TO REFLECT ‘FRIENDLY’
CARE ETHOS Greensleeves Homes Trust, a charity which runs 20 care homes across England, has re-launched as Greensleeves Care.
Greensleeves has said the rebrand has been undertaken in a bid to update the charity’s “look and feel”, as well as to “reflect the friendly nature of life” in its homes.
Assisted by marketing firm, The Help Agency, Greensleeves Care set up a series of focus groups including representatives from all of these groups to decide on a new direction for the brand.
Greensleeves Care Chief Executive, Paul Newman commented: “What was clear was that the primary emphasis should be on the care we provide. From our old name it was evident that some people thought our priority was bricks and mortar – so there was clearly a need for change.
ASPIRIN CAN HELP TREAT CANCER, SAYS
CARDIFF UNIVERSITY Research, conducted by Cardiff University, has suggested that patients receiving cancer treatment could increase their chance of survival by up to 20% and help stop their cancer from spreading by taking a low-dose of aspirin.
In a systematic review of the available scientific literature a team from the University’s School of Medicine found a significant reduction in mortality and cancer spread by patients who took a low-level dose of aspirin in addition to their cancer treatment.
Professor Peter Elwood, who led the research, commented: “There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers. Whilst we know a low-dose of aspirin has been
- 8 -
“With the sector becoming increasingly competitive and commercially aware, we know that a strong and positive brand that communicates what we are about is important in differentiating us from our competitors. This is particularly important given the rise of comparison websites.
“Plus, we wanted to involve our residents and our whole team.
It was
vital to us to have their input and their support for the new brand.”
Greensleeves’ new logo features lower case, less formal, lettering in British Racing Green to reflect the charity’s British heritage.
It
incorporates the strapline ‘You’re among friends’ to emphasise Greensleeves’ ethos of care.
shown to reduce the incidence of cancer, its role in the treatment of cancer remains uncertain. As a result, we set out to conduct a systematic search of all the scientific literature.”
The team’s review looked at all of the available data including five randomised trials and forty two observational studies of colorectal, breast and prostate cancers.
Professor Elwood added: “Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20%, together with a reduction in the spread of the cancer.
“The results from six studies of other cancers also suggest a reduction, but the numbers of patients were too few to enable confident interpretation. A mutation – known
The company’s new brand was unveiled at the annual Greensleeves Care Awards ceremony at The Oval, London, on April 12. Accolades were awarded across 11 categories including Innovation, Eating Experience, Carer of the Year and Home of the Year.
The awards were presented by Des Kelly OBE, Executive Director of the National Care Forum who said: “In my view only the best companies celebrate the achievements of their staff with the public recognition of awards. Care has the power to transform the quality of someone’s life – which is why what care workers do matters so much.
“I know from my own experience as a care assistant more than 40 years ago, you get immediate feedback for what you do and for this reason it can be immensely rewarding.
“It was wonderful to witness first-hand the pride and commitment of staff at Greensleeves Care to making a positive difference to people’s lives.”
www.greensleeves.org.uk
as PIK3CA – was present in about 20% of patients, and appeared to explain much of the reduction in colon cancer mortality by aspirin.
“One of the concerns about taking aspirin remains the potential for intestinal bleeding. That’s why we specifically looked at the available evidence of bleeding and we wrote to all authors asking for further data. In no study was serious or life- threatening bleeding reported.”
Professor Elwood continued: “While there is a desperate need for more detailed research to verify our review and to obtain evidence on less common cancers, we’d urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low-dose aspirin as part of their cancer treatment.”
www.cardiff.ac.uk www.tomorrowscare.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58